Migraine-Related Stroke in Childhood
Lancet 337:825-826, , 1991
The Bioloigcal Basis for the Treatment of Acute Stroke
Neurol 41:1867-1873, Scheinberg,P., 1991
Neurovascular Complications of Iatrogenic Fusarium solani Meningitis
NEJM 390:522-529, Strong, N.,et al, 2024
A 56-Year-Old Man with Unusual Presentation of Subacute Encephalopathy and Seizure
Neurol 98:e95-e102, Wang, T.,et al, 2022
MR Three-Territory Sign in Cancer-Associated Hypercoagulation Stroke (Trousseau Syndrome)
Neurologist 27:37-40, Finelli, P.F., 2022
Risk of First Ischaemic Stroke and Use of Antidopaminergic Antiemetics: Nationwide Case-Time-Control Study
BMJ 376:e061921, Benard-Laribiere, A.,et al, 2022
Mechanisms of Ischemic Stroke in Patients with Cancer
Ann Neurol 90:159-169, Navi, B.B.,et al, 2021
Epilepsy in Older People
Lancet 395:735-748, Sen, A.,et al, 2020
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19
NEJM 382:e38, Zhang, Y.,et al, 2020
Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Ischemic Stroke
Stroke 51:e124-e127, Valdes Valderrama, E.,et al, 2020
Fibrin and Platelet-Rich Composition in Retrieved Thrombi Hallmarks Stroke With Active Cancer
Stroke 51:3723-3727, Fu, C.H.,et al, 2020
A 14-Year-Old Girl with Headache, Seizures, and Confusion
Neurol 92:e161-e167, Xiao, L.,et al, 2019
Three Territory Sign
Neurol Clin Pract 9:124-128, Nouh, A.M.,et al, 2019
Clinicopathologic Conference, Statin-Associated Autoimmune Myopathy
NEJM 381:275-283, Case 22-2019, 2019
Circulating DNAs, a Marker of Neutrophil Extracellular Traposis and Cancer-Related Stroke
Stroke 50:2944-2947, Bang, O.Y.,et al, 2019
Clinicopathologic Conference, Pulmonary Adenocarcinoma, Complicated by a Hypercoagulable State with a Nonbacterial Thrombotic Endocarditis
NEJM, Case 33-2018, 2018
D-Dimer as a Predictor of Early Neurologic Deterioration in Cryptogenic Stroke with Active Cancer
Eur J Neurol 24:205-211, Nam, K.-W.,et al, 2017
Three Territory DWI Acute Infarcts: Diagnostic Value in Cancer-Associated Hypercoagulation Stroke (Trousseau Syndrome)
AJNR 37: Nov, Finelli, P.F. & Nouh, A., 2016
Clinicopathologic Conference, Acute Ischemic Stroke, Caused by Paradoxical Embolism Through a Patent Foramen Ovale, in a Patient with the May-Thurner Syndrome and a Hypercoagulable State Due to an Occult Renal-Cell Carcinoma
NEJM 374:1671-1680, Case 13-2016, 2016
Characteristics of Cryptogenic Stroke in Cancer Patients
Ann Clin Trans Neurol 3:280-287, Gon, Y.,et al, 2016
DWI Lesion Patterns in Cancer-Related Stroke-Specifying the Phenotype
Cerebrovasc Dis Extra 5:139-145, Schwarzbach, C.J.,et al, 2015
Evaluation of Cryptogenic Stroke with Advanced Diagnostic Techniques
Stroke 45:1186-1194, Bang, O.Y.,et al, 2014
Stroke and Cancer - A Complicated Relationship
J Neurol Transl Neurosci 2:1039-1051, Dearborn, J.L.,et al, 2014
Co-Occurrence of Multiple Cerebral Infarctions Due to Hypercoagulability Associated with Malignancy and Meningeal Carcinomatosis as the Initial Manifestation of Gastric Cancer
BMC Neurol 14:160, Kawasaki,A.,et al, 2014
Posterior cerebral artery susceptibility vessel sign on T2*-weighted gradient echo imaging
Neurol 77:e25, Roh, J.H.,et al, 2011
Clinicopath Conf, Intravascular Large-B-Cell Lympoma
NEJM 362:1129-1138, Case 9-2010, 2010
Angiotensin Receptor Blockers Should Be Regarded as First-Line Drugs for Stroke Prevention in Both Primary and Secondary Prevention Settings: No
Stroke 40:3161-3162, 3163, Strauss,M. &Hall,A., 2009
Angiotensin Receptor Blockers Should Be Regarded as First-Line Drugs for Stroke Prevention in Both Primary and Secondary Prevention Settings: Yes
Stroke 40:3159-3160, 3163, Hackam,D., 2009
Stroke Syndrome Secondary to Hypercoagulability of Lung Cancer
Commun Oncol 5:595-596, Lim, B. & Henry, D.H., 2008
Clinicopath Conf., Left Atrial Myxoma with Systemic Embolization
NEJM 357:1137-1145, Case 28-2007, 2007
Stroke as the First Manifestation of Concealed Cancer
J Neurol Sci 258:80-83, Kwon, H.M.,et al, 2007
Cerebral Vasoconstriction and Stroke After Use of Serotonergic Drugs
Neurol 58:130-133, Singhal,A.B.,et al, 2002
Vitamin D Deficiency and Risk of Hip Fractures Among Disabled Elderly Stroke Patients
Stroke 32:1673-1677, Sato,Y.,et al, 2001
Transient Ischaemic Attack in a Young Woman
Lancet 355:622, Lee,P. & Tse, H., 2000
Permanent Cortical Damage Detected by Flumazenil Positron Emission Tomography in Acute Stroke
Stroke 29:454-461, Heiss,W.,et al, 1998
Progression of Ischaemic Stroke and Excitotoxic Aminoacids
Lancet 349:79-83, Castillo,J.,et al, 1997
Functional & Metabolic Analysis of Cerebral Ischemia Using Magnetoencephalography & Proton MR Spectroscopy
Ann Neurol 42:554-563, 5391997., Kamada,K.,et al, 1997
Vitamin D Deficiency and Osteopenia in Hemiplegic Limbs of Stroke Patients
Stroke 27:2183-2187, Sato,Y.,et al, 1996
Clinical Experience with Excitatory Amino Acid Antagonist Drugs
Stroke 26:503-513, Muir,K.W.&Lees,K.R., 1995
Prophylactic Neuroprotection for Cerebral Ischemia
Stroke 25:1075-1080, Fisher,M.,et al, 1994
The Ischemic Penumbra, Injury Thresholds, and the Therapeutic Window for Acute Stroke
Ann Neurol 36:553-554, 5571994., Ginsberg,M.D.&Pulsinelli,W.A., 1994
Evolving Toward Effective Therapy for Acute Ischemic Stroke
JAMA 270:360-364, Fisher,M.&Bogousslavsky,J., 1993
Do NMDA Antagonists Prevent Neuronal Injury? Yes
ARch Neurol 49:418-420, Albers,G.W.,et al, 1992
Do NMDA Antagonists Prevent Neuronal Injury? No
Arch Neurol 49:420-421, Buchan,A.M., 1992
Tissue Plasminogen Activator Plus Glutamate Antagonist Improves Outcome after Embolic Stroke
Arch Neurol 48:1235-1238, Zivin,J.A.&Mazzarella,V., 1991
Treatment & Prognosis of Hemiballismus
NEJM 295:1348, Klawans,H.L.,et al, 1976